Register
Question 1
Which enzyme is responsible for removing RNA-DNA hybrids during lagging strand synthesis?
Correct Answer:
RNaseH
Explanation:
The enzyme responsible for removing RNA-DNA hybrids during lagging strand synthesis is RNase H. During DNA replication, especially on the lagging strand, RNA primers are synthesized to initiate the formation of Okazaki fragments. These RNA primers are essential for starting DNA synthesis because DNA polymerases require a free 3'-OH group to add nucleotides. Once the DNA synthesis catches up to the RNA primer section, the RNA must be removed to allow for a seamless DNA strand. RNase H specifically recognizes and degrades the RNA strand of RNA-DNA hybrids, facilitating the removal of these RNA primers. After RNase H acts on the hybrid, another enzyme, typically DNA polymerase, fills in the gaps by synthesizing DNA complementary to the remaining DNA template. This process ensures that the final DNA product is entirely composed of DNA, which is crucial for genomic integrity and function. The other enzymes mentioned have distinct roles in the replication process. Helicase unwinds the DNA double helix, DNA ligase joins the Okazaki fragments by sealing nicks in the sugar-phosphate backbone, and primase synthesizes the RNA primers necessary for initiating synthesis. None of these processes directly involve the removal of RNA-DNA hybrids during lagging strand synthesis,
Question 2
What can result from cystic fibrosis due to its genetic inheritance pattern?
Correct Answer:
Increased risk of lung infections
Explanation:
Cystic fibrosis is a genetic disorder caused by mutations in the CFTR gene, which is inherited in an autosomal recessive pattern. This means that an individual must inherit two copies of the mutated gene (one from each parent) to develop the disease. One of the primary consequences of cystic fibrosis is the production of thick, sticky mucus in various organs, particularly the lungs. This mucus obstructs the airways and creates an environment conducive to bacterial growth, leading to chronic lung infections. Over time, these recurrent infections can lead to serious lung damage and respiratory complications, significantly affecting the quality of life and overall health of individuals with cystic fibrosis. The other options—development of cancer, higher muscle mass, and enhanced cognitive ability—are not direct results of cystic fibrosis. While certain conditions and complications may arise in individuals with cystic fibrosis, none correlates positively with increased muscle mass or cognitive ability. Instead, the disease commonly results in a range of complications from poor nutritional absorption and reduced physical activity due to respiratory issues.
Question 3
Which exonuclease acts on both ends of single-stranded DNA?
Correct Answer:
Exonuclease VII
Explanation:
Exonuclease VII is characterized by its capability to act on both ends of single-stranded DNA, making it unique among the exonucleases listed. This enzyme specializes in the degradation of single-stranded DNA and can remove nucleotides from the 5' and 3' ends, thereby allowing it to process various forms of single-stranded DNA efficiently. This ability to act on both ends is particularly useful in molecular biology applications, such as preparing DNA for cloning or sequencing. By trimming back single-stranded regions from both ends, Exonuclease VII can facilitate the generation of blunt or cohesive ends required for ligation or other enzymatic reactions. In contrast, the other exonucleases mentioned have more specific activities; for instance, Exonuclease I primarily degrades single-stranded DNA from the 3' end, whereas Exonuclease III works on double-stranded DNA by removing nucleotides from the 3' ends. Mung Bean nuclease cuts single-stranded DNA but typically does not act on both ends in the same way as Exonuclease VII. Thus, Exonuclease VII is the best fit for the question regarding an enzyme that acts on both ends of single-stranded DNA
Question 4
Laboratory Developed Tests must include what type of disclaimer text?
Correct Answer:
Standard LDT disclaimer text
Explanation:
Laboratory Developed Tests (LDTs) are unique assays that are designed, manufactured, and used within a single laboratory, primarily for clinical diagnostics. The requirement for disclaimer text stems from the regulatory status of LDTs, which often operate outside of the strict regulations imposed on commercially marketed diagnostic tests by the FDA. The inclusion of standard LDT disclaimer text is essential as it informs users that the test has not undergone the same level of scrutiny and approval process as tests officially cleared or approved by the FDA. This is crucial for transparency, ensuring that healthcare providers and patients are aware that the test results may vary in reliability and validity compared to FDA-approved diagnostics. This disclaimer typically emphasizes that the test is developed in accordance with CLIA regulations but does not meet the additional standards of FDA review, serving as a communication tool regarding the nature and development process of the test. The presence of this text helps to manage expectations and educate users about the context in which the LDT operates.
Question 5
What type of bond links the nitrogen base and the ribose sugar in a nucleotide?
Correct Answer:
Glycosidic bond
Explanation:
In a nucleotide, the nitrogen base is linked to the ribose sugar through a glycosidic bond. A glycosidic bond forms between the anomeric carbon of the sugar (in this case, ribose) and a nitrogen atom in the nitrogenous base. This specific type of covalent bond is crucial for the structure of nucleic acids, allowing the formation of the backbone of DNA and RNA molecules. To elaborate, the glycosidic bond involves a condensation reaction that results in the loss of a water molecule, establishing a stable linkage that holds the nucleotide together. This bond plays a significant role in the overall structure and function of nucleic acids, as it determines how the sugar and base interact and maintain the integrity of the DNA or RNA strand. In contrast, the other types of bonds mentioned serve different roles in molecular biology. For instance, phosphodiester bonds link the sugar of one nucleotide to the phosphate group of another nucleotide, forming the backbone of DNA and RNA. Hydrogen bonds, on the other hand, are involved in pairing nitrogen bases with complementary bases across two strands of DNA. Ionic bonds typically occur between charged groups and are not relevant to the structure of nucleotides.
Question 1
Exam overview

About this Exam

The AAB Molecular Diagnostics Practice Test is an essential tool designed to help laboratory professionals prepare for the challenging American Association of Bioanalysts (AAB) Molecular Diagnostics Technologist (MDxT) Certification Exam. This certification is a prestigious validation of proficiency, designed for individuals working in or aspiring to lead in clinical molecular biology, genetics, and infectious disease laboratories. It benchmarks your knowledge in a rapidly evolving field, enhancing career opportunities and ensuring the highest standards of diagnostic testing. This practice test is curated to simulate the exam experience, allowing you to gauge your readiness and identify critical study areas.

More details

Additional Information

What the Course Entails and Exam Details

This practice test is structured to mirror the core domains covered in the official AAB MDxT exam specifications. It does not provide a separate course but acts as a diagnostic and preparatory instrument. The core knowledge and skills covered, and simulated in the practice questions, are broadly categorized into the following critical areas:

  • General Laboratory Operations: Including laboratory math, safety, quality control/quality assurance, regulations (CLIA, OSHA), and instrumentation fundamental to a molecular setting.

  • General Molecular Diagnostics Theory: Focusing on the principles of DNA and RNA structure, function, replication, transcription, and translation, as well as the molecular basis of inheritance and disease.

  • Molecular Laboratory Procedures: Simulating questions on specimen collection, processing, nucleic acid extraction methods (e.g., manual, automated), quantification, and stabilization.

  • Diagnostic Methods and Applications: The most heavily weighted section, covering diverse techniques like PCR (including real-time and digital), isothermal amplification, sequencing (Sanger and Next-Generation), microarrays, and their applications in areas such as infectious disease, oncology, genetics, and pharmacogenetics.


What to Expect in the Final Exam

The actual AAB MDxT Exam is a computer-based, multiple-choice assessment, designed to rigorously test both factual knowledge and its application in a clinical context. The final exam typically consists of hundreds of questions across the domains listed above. While AAB determines the exact number of questions and the time limit, candidates should prepare for a multi-hour session that requires sustained focus and critical thinking.

The passing score for the AAB MDxT exam is based on a scaled scoring system, which accounts for slight variations in the difficulty of different exam versions. Students should consult the latest AAB Board of Registry (BOR) documentation for the precise scaled passing score and number of questions. Retaking the exam requires adhering to specific waiting periods and re-application procedures. This practice test is designed to provide feedback on your scaled score probability, helping you to understand the conversion from your percentage correct to your predicted final exam outcome.


How to Study and Exam Centers

Preparation for the AAB MDxT exam requires a multi-faceted approach. Use this practice test as a core component of your strategy.

  • Actionable Study Strategies:

    • Diagnostic Testing: Take a complete practice test at the beginning of your study to create a baseline. Use the detailed feedback and category breakdowns to create a personalized study plan.

    • Official Guides: Deeply review the AAB Board of Registry’s content outline and competencies. Use this as your roadmap, ensuring every sub-topic is understood.

    • Active Learning: Don't just read. Summarize concepts, draw flowcharts for complex procedures (like NGS workflows or PCR reaction components), and explain topics to colleagues or in a study group.

    • Timed Practice: As you get closer to the exam, take practice tests in a single, uninterrupted setting, mimicking the time constraints to build stamina and practice time management.

    • Feedback Analysis: For every practice question missed, understand why the correct answer is correct and why your initial choice was incorrect. Address the knowledge gap immediately.

  • Exam Centers and Formats:

    • AAB Board of Registry (BOR) exams are proctored assessments. Traditionally, they are administered via computer at authorized, professional third-party testing centers, such as Pearson VUE or other AAB-designated locations. Some boards also offer live online proctoring options.

    • Action: Candidates must apply through the AAB Board of Registry first. Once eligibility is confirmed, you will receive instructions on how to register with the testing provider and select your specific exam date, time, and location (either in-person or online). Check the official AAB website for the most current information regarding available testing methods and center locations.


Job Opportunities from the Course

Earning your AAB Molecular Diagnostics Technologist (MDxT) Certification, combined with relevant education and experience, unlocks significant career growth in one of the fastest-growing areas of healthcare. This certification validates you as a specialized expert, making you a competitive candidate for positions such as:

  • Molecular Diagnostics Technologist

  • Molecular Biologist

  • Clinical Laboratory Scientist (Specializing in Molecular)

  • Medical Laboratory Scientist (with MDxT certification)

  • Technical Supervisor in Molecular Diagnostics

  • Molecular Laboratory Manager

  • Research Scientist (Clinical/Diagnostic focus)

  • Molecular Genetics Technologist

  • Infectious Disease Molecular Technologist

  • Assay Development Specialist (Molecular)

Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions

AAB Molecular Diagnostics Practice Exam

0 min

Basic Automotive Electrical Diagnostics Practice Test

0 min

SIE Diagnostics Practice Test Preparation

0 min

University of Central Florida (UCF) PCB3023 Molecular Cell Biology Practice Exam 4

0 min

University of Central Florida (UCF) PCB4524 Molecular Biology II Practice Exam 1

0 min

ASCP Molecular Biology (MB) Technologist Practice Exam

0 min